{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:20:59Z","timestamp":1762521659031,"version":"3.37.3"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.transproceed.2013.10.035","type":"journal-article","created":{"date-parts":[[2014,2,5]],"date-time":"2014-02-05T03:31:47Z","timestamp":1391571107000},"page":"241-244","source":"Crossref","is-referenced-by-count":34,"title":["Efficacy and Safety of Combination Therapy With Everolimus and Sorafenib for Recurrence of Hepatocellular Carcinoma After Liver Transplantation"],"prefix":"10.1016","volume":"46","author":[{"given":"P.","family":"De Simone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Crocetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Pezzati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Bargellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ghinolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Carrai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Della Pina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Cioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Pollina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Campani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bartolozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Lencioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Filipponi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2013.10.035_bib1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.6002\/ect.2012.0085","article-title":"Management of recurrent hepatocellular carcinoma in liver transplant recipients: a systematic review","volume":"10","author":"Rubin","year":"2012","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.transproceed.2013.10.035_bib2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jhep.2010.01.025","article-title":"Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: a proof of principle","volume":"52","author":"Bhoori","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.transproceed.2013.10.035_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jhep.2013.02.026","article-title":"Comparative efficacy of sorafenib versus best supportive care in recurrent hepatocellular carcinoma after liver transplantation: a case-control study","volume":"59","author":"Sposito","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.transproceed.2013.10.035_bib4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/MEG.0b013e328359e550","article-title":"Adverse events affect sorafenib efficacy in patients with recurrent hepatocellular carcinoma after liver transplantation: experience at a single center and review of the literature","volume":"25","author":"Zavaglia","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.transproceed.2013.10.035_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/lt.22434","article-title":"Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation","volume":"18","author":"Gomez-Martin","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2013.10.035_bib6","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/tri.12117","article-title":"Pre-transplant utilization of sorafenib is not associated with increased complications after liver transplantation","volume":"26","author":"Frenette","year":"2013","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2013.10.035_bib7","first-page":"2797","article-title":"Phase I adjuvant trial of sorafenib in patients with hepatocellular carcinoma after orthotopic liver transplantation","volume":"33","author":"Jia","year":"2013","journal-title":"Anticancer Res"},{"doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Per\u00e1lvarez M, Tsochatzis E, Naveas MC, Pieri G, Garc\u00eda-Caparr\u00f3s C, O\u2032Beirne J, et al. Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma [e-pub ahead of print]. J Hepatol http:\/\/dx.doi.org\/10.1016\/j.jhep.2013.07.012, published online July 15,\u00a02013.","key":"10.1016\/j.transproceed.2013.10.035_bib8","DOI":"10.1016\/j.jhep.2013.07.012"},{"key":"10.1016\/j.transproceed.2013.10.035_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.transproceed.2013.10.035_bib10","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/lt.23481","article-title":"Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance","volume":"18","author":"Banff Working Group on Liver Allograft Pathology","year":"2012","journal-title":"Liver Transpl"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134513010786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134513010786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T17:51:53Z","timestamp":1538848313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134513010786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0041134513010786"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2013.10.035","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}